"The U.S. Federal Trade Commission began investigating PBMs and their impact on patient access in 2022 and just released an interim report detailing its findings."
"Congress must address the negative impact that pharmacy benefit managers are having on patients' access to prescription drugs and pass PBM reform immediately."
"The FTC's actions to hold PBMs accountable highlight the dire need for Congress to act swiftly and pass PBM reform immediately."
"Restricting patients from accessing lower-cost medications and steering them away from local pharmacies exposes them to being overcharged for prescriptions."
#pharmacy-benefit-managers #healthcare-access #ftc-investigation #pharmacy-reform #independent-pharmacies
[
Collection
]
[
|
...
]